Skip to main content

Peer Review reports

From: A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials

Original Submission
22 Aug 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
14 Sep 2022 Reviewed Reviewer Report - Masahiro Kojima
23 Sep 2022 Reviewed Reviewer Report
29 Oct 2022 Author responded Author comments - Zuojing Li
Resubmission - Version 3
29 Oct 2022 Submitted Manuscript version 3
20 Nov 2022 Reviewed Reviewer Report - Masahiro Kojima
14 Dec 2022 Author responded Author comments - Zuojing Li
Resubmission - Version 4
14 Dec 2022 Submitted Manuscript version 4
17 Dec 2022 Author responded Author comments - Zuojing Li
Resubmission - Version 5
17 Dec 2022 Submitted Manuscript version 5
1 Jan 2023 Author responded Author comments - Zuojing Li
Resubmission - Version 6
1 Jan 2023 Submitted Manuscript version 6
4 Jan 2023 Author responded Author comments - Zuojing Li
Resubmission - Version 7
4 Jan 2023 Submitted Manuscript version 7
4 Jan 2023 Author responded Author comments - Zuojing Li
Resubmission - Version 8
4 Jan 2023 Submitted Manuscript version 8
2 Feb 2023 Author responded Author comments - Zuojing Li
Resubmission - Version 9
2 Feb 2023 Submitted Manuscript version 9
10 Feb 2023 Author responded Author comments - Zuojing Li
Resubmission - Version 10
10 Feb 2023 Submitted Manuscript version 10
Publishing
15 Feb 2023 Editorially accepted
2 Mar 2023 Article published 10.1186/s12874-023-01867-y

You can find further information about peer review here.

Back to article page